Short interest in MoonLake Immunotherapeutics (NASDAQ:MLTX) decreased during the last reporting period, falling from 7.80M to 7.68M. This put 29.54% of the company's publicly available shares short.

Short interest for MoonLake gives investors a sense of the degree to which investors are betting on the decline of MoonLake's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 575.25K shares traded per day, it would take 13.35 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.